洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2200067014】The Clinical Effectiveness of Virtual-Reality (VR) Assisted Tai Chi in Chronic Musculoskeletal Pain: A Randomized Clinical Trial

基本信息
登记号

ChiCTR2200067014

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2022-12-23

临床申请受理号

/

靶点

/

适应症

Chronic Musculoskeletal Pain

试验通俗题目

The Clinical Effectiveness of Virtual-Reality (VR) Assisted Tai Chi in Chronic Musculoskeletal Pain: A Randomized Clinical Trial

试验专业题目

The Clinical Effectiveness of Virtual-Reality (VR) Assisted Tai Chi in Chronic Musculoskeletal Pain: A Randomized Clinical Trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

Primary Aim: To assess the clinical effectiveness of VR assisted Tai Chi versus non-VR Tai Chi in adults with chronic MSK pain. Secondary aim: To assess the improvement in self-management of chronic pain, associated anxiety and depressive symptoms, and health-related quality of life.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

Ⅱ期

随机化

Randomization will be done in a 1:1 ratio using the Random Allocation Software by a statistician.

盲法

In this open-label study, blinding of participants will not be possible. However, research assistants and statisticians involved in data collection and analysis, respectively, were blinded to the allocation status.

试验项目经费来源

There was no funding support for this study.

试验范围

/

目标入组人数

40

实际入组人数

/

第一例入组时间

2022-12-26

试验终止时间

2024-07-31

是否属于一致性

/

入选标准

Participants aged 18 years or above with chronic musculoskeletal pain, defined as pain that lasted for more than 3 months persistently or intermittently, including regional pain (joints, limbs, back, and/or neck), a degenerative joint condition, such as osteoarthritis, and/or musculoskeletal complaints that fall under the chronic primary pain classification of the International Classification of Disease-11, pain intensity score >= 3 on a numerical rating scale of 10; stable baseline physical activity; and ability to understand written and verbal Chinese.;

排除标准

Participants with cancer-related pain, inflammatory rheumatic disease; a recent history of stroke or major surgery in the past 6 months; terminal illness; serious mental illness; severe or uncontrolled heart disease; major joint replacement or spinal surgery; comorbid conditions that might impede active participation in the study.;

研究者信息
研究负责人姓名
请登录查看
试验机构

The Chinese University of Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

The Chinese University of Hong Kong的其他临床试验

香港中文大學的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用